325 related articles for article (PubMed ID: 16478817)
1. Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients.
Roti E; Rossi R; Trasforini G; Bertelli F; Ambrosio MR; Busutti L; Pearce EN; Braverman LE; Degli Uberti EC
J Clin Endocrinol Metab; 2006 Jun; 91(6):2171-8. PubMed ID: 16478817
[TBL] [Abstract][Full Text] [Related]
2. Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two?
Arora N; Turbendian HK; Kato MA; Moo TA; Zarnegar R; Fahey TJ
Thyroid; 2009 May; 19(5):473-7. PubMed ID: 19348582
[TBL] [Abstract][Full Text] [Related]
3. Classification of papillary thyroid microcarcinoma according to size and fine-needle aspiration cytology: Behavior and therapeutic implications.
Friguglietti CU; Dutenhefner SE; Brandão LG; Kulcsar MA
Head Neck; 2011 May; 33(5):696-701. PubMed ID: 20737499
[TBL] [Abstract][Full Text] [Related]
4. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
[TBL] [Abstract][Full Text] [Related]
5. Papillary thyroid microcarcinoma: how to diagnose and manage this epidemic?
Soares P; Celestino R; Gaspar da Rocha A; Sobrinho-Simões M
Int J Surg Pathol; 2014 Apr; 22(2):113-9. PubMed ID: 24401191
[TBL] [Abstract][Full Text] [Related]
6. Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma.
Karatzas T; Vasileiadis I; Kapetanakis S; Karakostas E; Chrousos G; Kouraklis G
Am J Surg; 2013 Oct; 206(4):586-93. PubMed ID: 23790258
[TBL] [Abstract][Full Text] [Related]
7. Papillary thyroid microcarcinoma: a surgical perspective.
Sakorafas GH; Giotakis J; Stafyla V
Cancer Treat Rev; 2005 Oct; 31(6):423-38. PubMed ID: 16005155
[TBL] [Abstract][Full Text] [Related]
8. [Papillary thyroid microcarcinoma. Long-term outcome in 587 cases compared with published data].
Pelizzo MR; Merante Boschin I; Toniato A; Piotto A; Bernante P; Pagetta C; Casal Ide E; Mazzarotto R; Casara D; Rubello D
Minerva Chir; 2007 Oct; 62(5):315-25. PubMed ID: 17947943
[TBL] [Abstract][Full Text] [Related]
9. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
10. Lack of Efficacy of Radioiodine Remnant Ablation for Papillary Thyroid Microcarcinoma: Verification Using Inverse Probability of Treatment Weighting.
Kwon H; Jeon MJ; Kim WG; Park S; Kim M; Kim TY; Han M; Song DE; Sung TY; Yoon JH; Hong SJ; Ryu JS; Shong YK; Kim WB
Ann Surg Oncol; 2017 Sep; 24(9):2596-2602. PubMed ID: 28600731
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pathological characteristics of incidental and nonincidental papillary thyroid microcarcinoma in 339 patients.
Vasileiadis I; Karatzas T; Vasileiadis D; Kapetanakis S; Charitoudis G; Karakostas E; Kouraklis G
Head Neck; 2014 Apr; 36(4):564-70. PubMed ID: 23780707
[TBL] [Abstract][Full Text] [Related]
12. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
13. Clinical, histopathological, and molecular characteristics of papillary thyroid microcarcinoma.
Lim DJ; Baek KH; Lee YS; Park WC; Kim MK; Kang MI; Jeon HM; Lee JM; Yun-Cha B; Lee KW; Son HY; Kang SK
Thyroid; 2007 Sep; 17(9):883-8. PubMed ID: 17956162
[TBL] [Abstract][Full Text] [Related]
14. [Invasiveness of papillary thyroid microcarcinoma with BRAF mutation].
Yang X; Liang ZY; Meng C; Liang J; Yu Z; Lin YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):398-403. PubMed ID: 23987486
[TBL] [Abstract][Full Text] [Related]
15. Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients.
Pelizzo MR; Boschin IM; Toniato A; Piotto A; Bernante P; Pagetta C; Rampin L; Rubello D
Eur J Surg Oncol; 2006 Dec; 32(10):1144-8. PubMed ID: 16872798
[TBL] [Abstract][Full Text] [Related]
16. Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma.
Kim HJ; Kim NK; Choi JH; Kim SW; Jin SM; Suh S; Bae JC; Min YK; Chung JH; Kim SW
Clin Endocrinol (Oxf); 2013 Apr; 78(4):614-20. PubMed ID: 22957654
[TBL] [Abstract][Full Text] [Related]
17. Radioiodine remnant ablation in papillary thyroid microcarcinoma: a meta-analysis.
Yang T; Zheng SY; Jiao J; Zou Q; Zhang Y
Nucl Med Commun; 2019 Jul; 40(7):711-719. PubMed ID: 31095043
[TBL] [Abstract][Full Text] [Related]
18. [Clinical picture of differentiated thyroid carcinoma in the T1 stage].
Czarniecka A; Włoch J; Lange D
Wiad Lek; 2001; 54 Suppl 1():225-33. PubMed ID: 12182030
[TBL] [Abstract][Full Text] [Related]
19. Prognostic evaluation of patients with multicentric papillary thyroid microcarcinoma.
Kuo SF; Chao TC; Chang HY; Hsueh C; Yang CH; Lin JD
J Formos Med Assoc; 2011 Aug; 110(8):511-7. PubMed ID: 21783020
[TBL] [Abstract][Full Text] [Related]
20. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]